My day job… putting new drugs into people…Please don’t start on Northwick Park, the fall out from what was a reckless study by a small biotech, is still being felt daily.
There are good scientific reasons for a vaccine study for meningitis in universities. All those susceptibles coming together gives epidemics at the start of each new year. One often sees media reports of a death at this time of year.
Bacterial meningitis is driven my Neisseria menigitides and Haemophilus influenza and Streptoccocus pneumoniae. Vaccines for these are normally small segments of the bacterial coat, given to boost your immune system for when (if?) it sees the real thing. they are a good thing (TM).
I’d enter in a shot because there will be plenty of supporting data to show that the test vaccine (and of course the licensed vaccine) will promote an appropriate immune response with an acceptable safety profile. £30 is not much, but if it’s Hib, you may be too old to have been vaccinated in the past, so you will benefit from the trial on either treatment. They want to show that their bacterial coat (antigen) is at least as good as the marketed vaccine (which is now standard in the UK) and need to find a population with high enough incidence to test this (hence universities).
Still think it’s not worth £30?